Mudança de tratamento para o aflibercepte no tratamento da Degeneração Macular neovascular Relacionada à Idade: resultados de 30 meses

Autor: Ertan, Elif, Doğan, Mustafa, Polat, Onur, Efe, Neriman, Akdoğan, Müberra, İnan, Sibel, Duman, Reşat, Duman, Rahmi

PURPOSE: This study was conducted to evaluate visual function and changes in the central macular thickness of patients with unresponsive neovascular age-related macular degeneration who were switched from ranibizumab (Lucentis®) to aflibercept (Eyle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10184::6749583d63e15f59148f1e9ae0eeccf5
https://hdl.handle.net/20.500.12933/1161

Coats disease with retinal neovascularization under subfoveal nodule: optical coherence tomography-angiography findings before and after ranibizumab treatment

Autor: Ayşe İpek Akyüz Ünsal, Sema Oruç Dündar, Furkan Verdi

Publikováno v: Arquivos Brasileiros de Oftalmologia, Volume: 84, Issue: 4, Pages: 383-386, Published: 14 MAY 2021
Arquivos Brasileiros de Oftalmologia, Issue: ahead, Published: 14 MAY 2021

We conducted retinal neovascularization under subfoveal fibrotic nodule for Coats disease by using optic coherence tomography-angiography before and after ranibizumab treatment. Our patient was an 8-year-old boy who was referred with suspicious left

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f1f377b71472a53819aedbaf7e991f7
https://doi.org/10.5935/0004-2749.20210062

The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema

Autor: Toke Bek, Dorte Ancher Larsen, Nanna Stæhr Jakobsen

Publikováno v: Jakobsen, N S, Larsen, D A & Bek, T 2018, ' The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema ', Acta Ophthalmologica, vol. 96, no. 7, pp. 744-748 . https://doi.org/10.1111/aos.13773

PURPOSE: Diabetic maculopathy can be treated with intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors. However, the therapy is not effective in all patients, and it would be desirable to have parameters for differentiating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6aeeb6f9d5ebbd6c1dd56955ddff4be
https://doi.org/10.1111/aos.13773

Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration

Autor: Zhao, Min, Mantel, Irmela, Gelize, Emmanuelle, Li, Xinxin, Xie, Xiaoyue, Arboleda, Alejandro, Seminel, Marie, Levy-Boukris, Rinath, Dernigoghossian, Marilyn, Prunotto, Andrea, Andrieu-Soler, Charlotte, Rivolta, Carlo, Canonica, Jérémie, Naud, Marie-Christine, Lechner, Sebastian, Farman, Nicolette, Bravo-Osuna, Irene, Herrero-Vanrell, Rocio, Jaisser, Frederic, Behar-Cohen, Francine

Publikováno v: Nature Communications
Nature Communications, Nature Publishing Group, 2019, 10 (1), pp.369. ⟨10.1038/s41467-018-08125-6⟩
Nature communications, vol. 10, no. 1, pp. 369
Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)

Choroidal neovascularization (CNV) is a major cause of visual impairment in patients suffering from wet age-related macular degeneration (AMD), particularly when refractory to intraocular anti-VEGF injections. Here we report that treatment with the o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::228cace5caba338259e157d974dc8c97
https://hal.sorbonne-universite.fr/hal-01997678

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.